Skip to main content Skip to navigation

Jason Madan

Job Title
Professor
Department
WMS - Warwick Clinical Trials Unit
Phone
02476151254
Web Link
Research Interests

Economic Evaluation; Bayesian Methods; Evidence Synthesis; Global Health Economics

Biography

Dr Madan is a Professor in Health Economics at Warwick Medical School, and Director of Graduate Research Studies for the School. His research involves the application of economic methods to health technology assessment in a wide range of clinical settings, including cancer, mental health, and tuberculosis. He is particularly interested in the use of decision modelling and Bayesian methods to inform health policy. His current responsibility as director of PGR programmes builds on his experience of developing and delivering health economics training for both specialists and non-specialists, and his enthusiasm for encouraging and supporting postgraduate research students.

Title Funder Award start Award end
Awake prone positioning in patients with acute hypoxaemic respiratory failure not due to COVID-19: a multi-centre, pragmatic, allocation concealed, individual patient randomised, parallel group, open-label clinical trial (AWAKE-PRONE) National Institute for Health Research (NIHR DoH) 01 Jan 2024 31 Dec 2027
MRC GACD: ISOBAR: Implementing Early Mental & Physical Health Detection & Support: Promoting a Whole-School Approach to Health & Well-being MRC 02 Oct 2023 01 Oct 2027
NIHR HTA Stage 2:RESTORE Lead by UHCW. Award Reference NIHR157510 National Institute for Health Research (NIHR DoH) 01 Jul 2024 31 Mar 2027
TAR 3 - Production of Technology Assessment Reviews (TAR) National Institute for Health Research (NIHR DoH) 01 Apr 2022 31 Mar 2027
COBIx: Multi-site validation of automated AI tool for screening of large bowel endoscopic biopsy slides National Institute for Health Research (NIHR DoH) 01 Apr 2023 31 Mar 2026
High-quality Mental Capacity Act assessments for Everyone: improving Leadership, assessment Procedures, and patient Support (HELPS) (NIHR HSDR Stage 2) National Institute for Health Research (NIHR DoH) 01 Sept 2023 28 Feb 2026
Pathways for Innovation in Blood Transfusion Services in Kenya National Institutes of Health 01 Oct 2022 30 Sept 2025
NIHR RIGHT programme - Stage 2: TRANSFORM project (related to 61743 outline): An asseT-based appRoAch FOR improving access to Mental health care in slums: the TRAnsFORM Project National Institute for Health Research (DoH) 01 Sept 2020 31 Aug 2025
Modelling for the HAT Endgame Gates Foundation 19 Nov 2020 30 Apr 2025
NIHR HPRU in Gastrointestinal Infections National Institute for Health Research (DoH) 01 Apr 2020 31 Mar 2025
NIHR: Rehab after ICU_Lead by Ulster University National Institute for Health Research (NIHR DoH) 01 Jan 2022 31 Dec 2024
PIPA Trial Costed Extension Linked to IDEATE 57047 National Institute for Health Research (NIHR DoH) 01 Dec 2022 30 Nov 2024
ARC 2018: NIHR Applied Research Collaborations National Institute for Health Research (DoH) 01 Oct 2019 30 Sept 2024
NIHR HTA Costed Extenison: Digital Pathology_Linked to Main award on IDEATE 58038 National Institute for Health Research (NIHR DoH) 01 Nov 2021 30 Apr 2023
NIHR PHR via University of Cardiff: Optimisation, feasibility testing and pilot randomised trial of SaFE: a sexual health and healthy relationships intervention for Further Education National Institute for Health Research (DoH) 01 Jan 2020 31 Mar 2023
STREAM: The evaluation of a standard treatment regimen of anti-tuberculosis drugs for patients with MDR-TB : Extension_Funding forApril 2022 to February 2023 . Linked to IDEATE 58916 Vital Strategies, Inc 01 Apr 2022 28 Feb 2023
NIHR HTA Satage 2:What is the comparative clinical and cost- effectiveness of pharmacological treatments for adults with chronic migraine? National Institute for Health Research (NIHR DoH) 01 Sept 2021 28 Feb 2023
NIHR Global Health Research Group on the Application of Genomics and Modelling to the Control of Virus Pathogens (GeMVi) in East Africa at the University of Warwick. Costed ext linked to 56618 National Institute for Health Research (NIHR DoH) 01 Apr 2021 30 Sept 2022
NIHR TAR2 12 month extension and supplement - orginal award on IDEATE number 00169 under Aileen Clarke National Institute for Health Research (DoH) 01 Apr 2021 31 Mar 2022
Standardized Treatment ReginEN of Anti-tuberculosis drugs for patients with Multi-drug-resistent tuberculosis(STREAM) : Extension_Funding for Oct 2019 to March 2022. Linked to IDEATE 58916 Vital Strategies, Inc 01 Oct 2019 31 Mar 2022
NIHR WIC Extension National Institute for Health Research (DoH) 01 Jul 2020 31 Jan 2022
NIHR HTA: Whole slide imaging in pathology National Institute for Health Research (DoH) 01 Nov 2018 31 Oct 2021
HAT Modelling and Economic Predictions for Policy (HAT MEPP) Gates Foundation 09 Nov 2017 31 Oct 2021
NIHR Global Health Research Group on the Application of Genomics and Modelling to the Control of Virus Pathogens (GeMVi) in East Africa National Institute for Health Research (DoH) 01 Apr 2018 31 Mar 2021
Standardized Treatment ReginEN of Anti-tuberculosis drugs for patients with Multi-drug-resistent tuberculosis(STREAM) Funding for 2017/2019 International Union Against Tuberculosis and Lung Disease (The Union) 01 Oct 2017 30 Sept 2019
ADCARE via UCL National Institute for Health Research (DoH) 01 Jul 2016 30 Jun 2019
Research Network for the Evaluation of Complex Service Delivery Interventions in LMIC settings Academy of Medical Sciences 01 Mar 2018 31 May 2019
EU FP7 Health 2013 - FULL Proposal: MILESTONE EU 01 Feb 2014 30 Apr 2019
MRC Methodology- Bayesian adaptive methodology for HTA trials MRC 01 Oct 2016 31 Mar 2019
Wound Healing in Surgery for Trauma Trial A Randomised Controlled Trial of standard wound management versus negative pressure wound therapy in the treatment of adult patients having surgical incisions for major trauma to the lower limb. WHIST via Oxford National Institute for Health Research (DoH) 01 Jan 2016 31 Dec 2018
Evaluating the Use of Patient Experience Data to Improve the Quality of Inpatient Mental Health Care National Institute for Health Research (DoH) 01 Dec 2015 30 Nov 2018
UKNSC Tender Public Health England 01 Oct 2015 30 Sept 2018
Evaluating the Effects of Community Treatment Orders (CTOs) in England Using the Mental Health Minimum Dataset National Institute for Health Research (DoH) 01 Jan 2016 31 Aug 2018
Standardized Treatment RegimEN of Anti-tuberculosis drugs for patients with Multi-drug-resistant tuberculosis (STREAM) International Union Against Tuberculosis and Lung Disease (The Union) 01 Oct 2016 30 Sept 2017
Health economics of pathology services in relation to cancer diagnosis and treatment selection (WCPRS) Omnyx LLC 01 Feb 2015 31 Dec 2016
EU FP7 Health Call 2013.4.2-3 (FULL Proposal): InsPiRe - Innovative Methodology for Small Populations Research European Commission 01 Sept 2013 30 Nov 2016
Bladder Path: Image directed redesign of bladder cancer treatment pathways 46647 Award re-cost - HTA Full - Biomarker Trial National Institute for Health Research (DoH) 01 Apr 2016 30 Sept 2016
Primary care treatment of pain-related insomnia: A feasibility study of ahybrid cognitive-behavioural approach National Institute for Health Research (DoH) 01 Apr 2014 30 Sept 2016
NIHR RfPB (Round 19): Warwick Arthroplasty Infection Trial - A feasibility study National Institute for Health Research (DoH) 01 Jun 2013 31 May 2016
Omnyx Centre of Excellence - Health Economics v.2 Omnyx LLC 01 Apr 2015 31 Mar 2016
NIHR HSDR FULL proposal - LYNC: Long term conditions, young people and network communications National Institute for Health Research (DoH) 01 Mar 2014 29 Feb 2016
CHAPAS3 - UoW subcontract with University of York Cipla Limited 01 Jan 2015 31 Dec 2015
Standardized Treatment RegimEN of Anti-tuberculosis drugs for patients with Multi-drug-resistant tuberculosis (STREAM) International Union Against Tuberculosis and Lung Disease (The Union) 01 Oct 2014 30 Sept 2015